Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - QUEST DIAGNOSTICS INCdgx12312017ex322.htm
EX-32.1 - EXHIBIT 32.1 - QUEST DIAGNOSTICS INCdgx12312017ex321.htm
EX-31.2 - EXHIBIT 31.2 - QUEST DIAGNOSTICS INCdgx12312017ex312.htm
EX-31.1 - EXHIBIT 31.1 - QUEST DIAGNOSTICS INCdgx12312017ex311.htm
EX-21.1 - EXHIBIT 21.1 - QUEST DIAGNOSTICS INCdgx12312017ex211.htm
EX-10.9 - EXHIBIT 10.9 - QUEST DIAGNOSTICS INCdgx123117ex109.htm
EX-10.4 - EXHIBIT 10.4 - QUEST DIAGNOSTICS INCdgx123117ex104.htm
10-K - 10-K - QUEST DIAGNOSTICS INCdgx1231201710-k.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-211336) and Form S-8 (Nos. 333-184580, 333-182863, 333-143889, 333-136196, 333-136195, 333-60758, 333-60477, 333-157447, 333-162710, 333-162711, 333-207746, 333-214215 and 333-221076) of Quest Diagnostics Incorporated of our report dated February 23, 2018 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


By
/s/ PricewaterhouseCoopers LLP
 
 
 
PricewaterhouseCoopers LLP
 
 
 
Florham Park, New Jersey
 
February 23, 2018